Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency Inhibits Pathological Cardiac Hypertrophy
Yinhui Wang(Tongji Hospital), Chunxia Zhao(The University of Adelaide), Chengcheng Zhao(Tongji Hospital), Jia Song(Huazhong University of Science and Technology), Daan Nie(Guiyang Medical University), Feng Wang(Huazhong University of Science and Technology), Jia Cheng(Tongji Hospital), Shu Zhang(Tongji Hospital), Wen Zheng(Unknown), Junfang Wu(Laboratory of Molecular Genetics), Qilin Yu(Tongji Hospital), Ling Zhou(Shanghai Changzheng Hospital), Kun Yu(Tongji Hospital), Liping Jiao(Shanxi Academy of Medical Sciences), Dao Wen Wang(Tongji Hospital), Ziyi Wang(Tongji Hospital), Cong‐Yi Wang(Ministry of Education of the People's Republic of China)
Cited by 17
Related Papers
A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes
|Nature Genetics|2004|423
The role of CD36 in cardiovascular disease
|Cardiovascular Research|2020|273
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program
|Science Advances|2021|233
Gut Microbiota Composition Modifies Fecal Metabolic Profiles in Mice
|Journal of Proteome Research|2013|225